GlassScriptPhysician profile
Michaela Sandra Bleyl
NPI 1902527401
$1,006.66
in general payments reported to CMS, 2019-2025
16 companies · $385 in 2025
The $385 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $39.41 · 2023: $107 · 2024: $475 · 2025: $385.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $967.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $967.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $190.61 | 2023-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $149.54 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $130.72 | 2022-2025 | Jardiance |
| Abbvie INC. | $91.10 | 2023 | |
| Pfizer INC. | $72.40 | 2024-2025 | |
| Kiniksa Pharmaceuticals International, Plc | $67.72 | 2024 | Arcalyst |
| E.R. Squibb & Sons, L.L.C. | $64.84 | 2024-2025 | Camzyos |
| Actelion Pharmaceuticals US, INC. | $39.65 | 2024 | Opsumit, Uptravi |
| Daiichi Sankyo INC. | $33.53 | 2024-2025 | Injectafer |
| Merck Sharp & Dohme LLC | $31.25 | 2025 | Verquvo, Winrevair |
| Boston Scientific Corporation | $28.67 | 2025 | Watchman Flx |
| Regeneron Healthcare Solutions, INC. | $25.69 | 2025 | Praluent, Evkeeza |
| Lexicon Pharmaceuticals, INC. | $22.76 | 2024 | |
| Heartflow, INC. | $22.43 | 2025 | |
| Ultragenyx Pharmaceutical INC. | $20.82 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $14.93 | 2024 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michaela Bleyl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.